These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study. Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255 [TBL] [Abstract][Full Text] [Related]
27. An influenza A/H3 outbreak during the 2004/2005 winter in elderly vaccinated people living in a nursing home. Iorio AM; Neri M; Lepri E; Camilloni B; Basileo M; Sigismondi N; Fabiani C; Calzoletti L; Puzelli S; Donatelli I Vaccine; 2006 Nov; 24(44-46):6615-9. PubMed ID: 16828941 [TBL] [Abstract][Full Text] [Related]
28. HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. Spencer MJ; Cherry JD; Terasaki PI N Engl J Med; 1976 Jan; 294(1):13-6. PubMed ID: 1105178 [TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Bracco Neto H; Farhat CK; Tregnaghi MW; Madhi SA; Razmpour A; Palladino G; Small MG; Gruber WC; Forrest BD; Pediatr Infect Dis J; 2009 May; 28(5):365-71. PubMed ID: 19395948 [TBL] [Abstract][Full Text] [Related]
30. Serum SRH antibody level as a measure of the immunity against natural and artificial A/Victoria/3/75 infections. Delem A Dev Biol Stand; 1977 Jun 1-3; 39():391-6. PubMed ID: 342314 [TBL] [Abstract][Full Text] [Related]
32. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
33. Vaccination-induced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 1996-1997 epidemic season. Pyhälä R; Ikonen N; Santanen R; Haanpää M; Visakorpi R; Jäppinen P; Valle M J Med Virol; 2001 Nov; 65(3):584-9. PubMed ID: 11596097 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. Rhorer J; Ambrose CS; Dickinson S; Hamilton H; Oleka NA; Malinoski FJ; Wittes J Vaccine; 2009 Feb; 27(7):1101-10. PubMed ID: 19095024 [TBL] [Abstract][Full Text] [Related]
35. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S; Süss J; Oehring H; Schmidt J Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [TBL] [Abstract][Full Text] [Related]
36. Immunization of man and animals against influenza by oral and intranasal routes. Boudreault A; Boulay G; Marois P; Pavilanis V Dev Biol Stand; 1976; 33():171-7. PubMed ID: 782965 [TBL] [Abstract][Full Text] [Related]
38. Influenza A infections in young children. Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. Wright PF; Ross KB; Thompson J; Karzon DT N Engl J Med; 1977 Apr; 296(15):829-34. PubMed ID: 846492 [TBL] [Abstract][Full Text] [Related]
39. Small-scale field trial with neuraminidase vaccine. Vonka V; Závadová H; Brůj J; Skocil V; Janout V; Uvizl M; Kotíková J Dev Biol Stand; 1977 Jun 1-3; 39():337-9. PubMed ID: 342313 [TBL] [Abstract][Full Text] [Related]
40. Challenge versus natural infection as an index or protection after influenza immunization. Donikian MA; McKee J; Greene LC Dev Biol Stand; 1977 Jun 1-3; 39():149-54. PubMed ID: 342306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]